Globus Medical, Inc. (GMED) Earnings History
Annual and quarterly earnings data from 2010 to 2025
Loading earnings history...
GMED EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GMED Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 67.4% | 16.3% | 18.3% |
| 2024 | 58.9% | 6.6% | 4.1% |
| 2023 | 65.1% | 8.5% | 7.8% |
| 2022 | 74.2% | 22.3% | 18.6% |
| 2021 | 75.0% | 17.9% | 15.6% |
Download Data
Export GMED earnings history in CSV or JSON format
Free sign-in required to download data
Globus Medical, Inc. (GMED) Earnings Overview
As of May 8, 2026, Globus Medical, Inc. (GMED) reported trailing twelve-month net income of $587M, reflecting +422.7% year-over-year growth. The company earned $4.25 per diluted share over the past four quarters, with a net profit margin of 18.3%.
Looking at the long-term picture, GMED's 5-year EPS compound annual growth rate (CAGR) stands at +31.2%, indicating exceptional earnings growth. The company achieved its highest annual net income of $538M in fiscal 2025, representing a new all-time high.
Globus Medical, Inc. maintains industry-leading profitability with a gross margin of 67.4%, operating margin of 16.3%, and net margin of 18.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including SYK ($3.25B net income, 12.9% margin), ZBH ($761M net income, 8.6% margin), ATEC (-$125M net income, -18.8% margin), GMED has outperformed on profitability metrics. Compare GMED vs SYK →
GMED Earnings vs Peers
Earnings metrics vs comparable public companies
GMED Historical Earnings Data (2010–2025)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $538M | +422.3% | $480M | $3.92 | 18.3% | 16.3% |
| 2024 | $103M | -16.2% | $166M | $0.75 | 4.1% | 6.6% |
| 2023 | $123M | -35.4% | $133M | $1.07 | 7.8% | 8.5% |
| 2022 | $190M | +27.5% | $228M | $1.85 | 18.6% | 22.3% |
| 2021 | $149M | +45.9% | $172M | $1.44 | 15.6% | 17.9% |
| 2020 | $102M | -34.1% | $111M | $1.01 | 13.0% | 14.1% |
| 2019 | $155M | -0.8% | $172M | $1.52 | 19.8% | 21.9% |
| 2018 | $156M | +45.8% | $169M | $1.54 | 21.9% | 23.7% |
| 2017 | $107M | +2.9% | $162M | $1.10 | 16.9% | 25.4% |
| 2016 | $104M | -7.5% | $154M | $1.08 | 18.5% | 27.3% |
Full GMED Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See GMED's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GMED Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GMED vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGMED — Frequently Asked Questions
Quick answers to the most common questions about buying GMED stock.
Is GMED growing earnings?
GMED EPS is $4.25, with earnings growth accelerating to +422.7%. This exceeds the 5-year CAGR of +31.2%. TTM net income reached $587M.
What are GMED's profit margins?
Globus Medical, Inc. net margin is +18.3%, with operating margin at +16.3%. Above-average margins indicate pricing power.
How consistent are GMED's earnings?
GMED earnings data spans 2010-2025. The accelerating earnings trend is +422.7% YoY. Historical data enables comparison across business cycles.